Continuity of Patient CareSCORDOMNCT06288295
Retrospective Study on Data Aiming to Establish a Prediction Score for Return Home at the Time of Admission to a Multidisciplinary Medical Department (SCORDOM
An observational study of Continuity of Patient Care, run by Elsan at 1 site in France.
Trial summary
The goal of this observational study is to define clinical, biological and socio-cultural criteria, from the very first days of hospitalization on the multidisciplinary medicine department, to guide the patient's discharge from hospital (return to home when discharged from hospital). Read more about this study
- Who is it for?
- Ages 60 years and older
- Conditions the study is for
- Continuity of Patient Care
- How many people
- 600 participants
- Where
- 1 siteFrance
- Study dates
- 1 Oct 2021to 28 Feb 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients over 60 years of age, hospitalized in Nancy private Hospital Lorraine, in the multidisciplinary medical department, between october 2021 and February 2022, and patients hospitalized between October 2022 and February 2023 (in the same department).
Who may be able to join
- For the development of the score:
- All patients over 60 years of age admitted to the multidisciplinary medical department in the investigating center between October 2021 and February 2022.
- Patients for whom data of interest to this study are available in medical records.
- For score validation :
- All patients aged over 60 admitted to the multidisciplinary medicine department of the investigating center between October 2022 and February 2023.
- Patients for whom data of interest to this study are available in medical records.
Who cannot join
- Patients transferred from an intensive care or continuing care unit
- Patients in palliative care
- Patients residing in an EHPAD (establishment for the elderly) or nursing home prior to hospitalization
- Patients without a minimum blood test on admission (blood test less than 48 hours old)
- Patients whose reason for hospitalization is due to COVID
- Patients who have objected to the use of their personal data
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Retrospective Study on Data Aiming to Establish a Prediction Score for Return Home at the Time of Admission to a Multidisciplinary Medical Department
The goal of this observational study is to define clinical, biological and socio-cultural criteria, from the very first days of hospitalization on the multidisciplinary medicine department, to guide the patient's discharge from hospital (return to home when discharged from hospital).
The data collected will be those contained in the medical records of patients over 60 years of age who were admitted to the multidisciplinary medical department between October 2021 and February 2022 and between October 2022 and February 2023.
Read more
This study also aims at developing and validating a predictive score of orientation at the end of hospitalisation.
Participants are patients previously hospitalized. They will be informed about the study by post and will be able to object to the use of his or her data.
- Conditions
- Continuity of Patient Care
- Keywords
- predictive score, return to home, elderly
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Score development cohort | Patients over 60 years of age admitted to a general medicine department in the investigating center between October 2021 and February 2022 | |
| Score validation cohort | Patients over 60 years of age admitted to a general medicine department in the investigating center between October 2022 and February 2023 |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of patients with a return to home after hospitalization and with similar clinical parameters, similar age category, similar pathology and similar biological parameters
Data collected among hospital data from october 2021 to february 2022. Clinical parameters measured: age, confusional syndrome, fever, eschar, blood pressure, etc; biological paremeters: (blood test performed in the last 2 days before discharge: albuminemia, natremia, protein C, Creatinemy, hemoglobinemy)
Measured: Hospital stay, up to 3 weeks
Secondary outcomes (1)
Number of patients with a return to home after hospitalization and with similar clinical parameters, similar age category, similar pathology and similar biological parameters
Data collected among hospital data from october 2022 to february 2023. Clinical parameters measured: age, confusional syndrome, fever, eschar, blood pressure, etc; biological paremeters: (blood test performed in the last 2 days before discharge: albuminemia, natremia, protein C, Creatinemy, hemoglobinemy)
Measured: Hospital stay, up to 3 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Mar 2024
- Study start1 Oct 2021
- Primary completion28 Feb 2023
- Study completion28 Feb 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Continuity of Patient CareStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 600 participants (actual)
Sponsor and investigators
- Lead sponsor
- Elsan
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Anais Bauer, PhD, Principal investigator, Hôpital Privé Nancy Lorraine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06288295
- Sponsor's protocol ID
- Etude SCORDOM
- Acronym
- SCORDOM
- Status last verified
- Feb 2024
- First submitted
- 9 Feb 2024
- Last updated
- 1 Mar 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Mar 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Retrospective Study on Data Aiming to Establish a Prediction Score for Return Home at the Time of Admission to a Multidisciplinary Medical Department
- ClinicalTrials.gov ID
- NCT06288295
- Acronym / sponsor ID
- SCORDOM / Etude SCORDOM
- Conditions
- Continuity of Patient Care
- Keywords
- predictive score, return to home, elderly
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 600 participants (actual)
- Lead sponsor
- ElsanUniversity, hospital or other
- Study start
- 1 Oct 2021 (actual)
- Primary completion
- 28 Feb 2023 (actual)
- Study completion
- 28 Feb 2023 (actual)
- First posted
- 1 Mar 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to define clinical, biological and socio-cultural criteria, from the very first days of hospitalization on the multidisciplinary medicine department, to guide the patient's discharge from hospital (return to home when discharged from hospital).
The data collected will be those contained in the medical records of patients over 60 years of age who were admitted to the multidisciplinary medical department between October 2021 and February 2022 and between October 2022 and February 2023.
This study also aims at developing and validating a predictive score of orientation at the end of hospitalisation.
Participants are patients previously hospitalized. They will be informed about the study by post and will be able to object to the use of his or her data.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Score development cohort | – | –Patients over 60 years of age admitted to a general medicine department in the investigating center between October 2021 and February 2022 |
| Score validation cohort | – | –Patients over 60 years of age admitted to a general medicine department in the investigating center between October 2022 and February 2023 |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients over 60 years of age, hospitalized in Nancy private Hospital Lorraine, in the multidisciplinary medical department, between october 2021 and February 2022, and patients hospitalized between October 2022 and February 2023 (in the same department).
Key inclusion criteria (6 listed)
- All patients over 60 years of age admitted to the multidisciplinary medical department in the investigating center between October 2021 and February 2022.
- Patients for whom data of interest to this study are available in medical records.
- All patients aged over 60 admitted to the multidisciplinary medicine department of the investigating center between October 2022 and February 2023.
- Patients for whom data of interest to this study are available in medical records.
Key exclusion criteria (6 listed)
- Patients transferred from an intensive care or continuing care unit
- Patients in palliative care
- Patients residing in an EHPAD (establishment for the elderly) or nursing home prior to hospitalization
- Patients without a minimum blood test on admission (blood test less than 48 hours old)
- Patients whose reason for hospitalization is due to COVID
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Number of patients with a return to home after hospitalization and with similar clinical parameters, similar age category, similar pathology and similar biological parameters
Time frame: Hospital stay, up to 3 weeks
Data collected among hospital data from october 2021 to february 2022. Clinical parameters measured: age, confusional syndrome, fever, eschar, blood pressure, etc; biological paremeters: (blood test performed in the last 2 days before discharge: albuminemia, natremia, protein C, Creatinemy, hemoglobinemy)
1 secondary outcome
Number of patients with a return to home after hospitalization and with similar clinical parameters, similar age category, similar pathology and similar biological parameters
Time frame: Hospital stay, up to 3 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Mar 2024.
Related trials for Continuity of Patient Care
Not yet recruitingObservational study
Clinical Governance of Home Care and 30-Day Stability
Home Care Services, Quality of Health Care
Enrolling by invitation
TimelyCare - A Proactive Primary Care Model: Delivering the Right Care at the Right Time for Individuals at Risk of High Care Consumption
Multimorbidity, Integrated Care
Active, not recruitingObservational study
Transition From Pediatric to Adult Care in Young Adults With Acquired Brain Injury
Acquired Brain Injury
Recruiting
Case Management Dyad
HIV, Pre-exposure Prophylaxis
Recruiting
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
Hepatitis C
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anais Bauer, PhD principal investigator
Hôpital Privé Nancy Lorraine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Continuity of Patient Care, run by Elsan at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of patients with a return to home after hospitalization and with similar clinical parameters, similar age category, similar pathology and similar biological parameters (time frame: Hospital stay, up to 3 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Mar 2024.